Thursday, November 19, 2009
Print Current Day:
|
|
SESSION 7 SCHEDULE | |
x | |
7:35 AM - 7:40 AM | Opening Remarks |
Presenters(s):Jacob Cynamon, MD | |
7:40 AM - 8:40 AM | Case Presentations: Multidisciplinary Approach Yields The Best Approach |
Presenters(s):Jean Francois H. Geschwind, MD / | |
END OF SESSION 7 | |
SESSION 8 SCHEDULE | |
x | |
8:40 AM - 9:40 AM | Hands-On Percutaneous Tumor Ablation: RF, Cryo, Microwave, IRE |
Presenters(s):Joshua L. Weintraub, MD, FSIR / | |
END OF SESSION 8 | |
SESSION 9 SCHEDULE | |
Thursday
SESSION 9:
ONCOLOGY WORKSHOP 3
xxxxxxxx xxxx |
|
x | |
9:40 AM - 10:40 AM | Chemoembolization And Y90 |
Presenters(s):Jean Francois H. Geschwind, MD / Karen T. Brown, MD / Jonathan Susman, MD | |
END OF SESSION 9 | |
SESSION 10 SCHEDULE | |
Thursday
SESSION 10:
HOT TOPICS IN LOWER EXTREMITY ENDOVASCULAR TREATMENT (5-MINUTE TALKS)
xxxx
Moderators:Jacob Cynamon, MD
|
|
x | |
6:40 AM - 6:45 AM | Opening Remarks |
Presenters(s):Frank J. Veith, MD | |
6:45 AM - 6:50 AM | Overview Of Atherectomy Devices: What Is The Evidence They Add Anything But Cost? |
6:51 AM - 6:56 AM | Debate 4: Rotational Atherectomy Devices Really Work In Certain Specific Situations: What Are They? What Is The Proof? |
6:57 AM - 7:03 AM | Debate 4: Atherectomy Devices Are A Waste Of Time And Money |
7:04 AM - 7:09 AM | Value And Limitations Of The ANGIOSCULPT Scoring/Cutting PTA Balloon For Infrapopliteal Lesions: 2-Year Results Of The MASCOT Trial: Will This Decrease The Need For Stents? |
7:10 AM - 7:15 AM | Cool Excimer Laser Assisted PTA vs. Balloon PTA With New Improved Balloons For Tibial Occlusive Disease Causing Critical Limb Ischemia (CLI): Is The Laser Of Real Value And When? |
7:16 AM - 7:21 AM | Tips, Tricks And Bailout Strategies For Subintimal Angioplasty Of Long Infrainguinal Occlusions |
7:22 AM - 7:27 AM | Debate 5: Update And 12-Month Results With Drug Eluting Balloons Show Clear Benefit For Treating SFA And Popliteal Lesions |
7:28 AM - 7:33 AM | Debate 5: It Is Not So Clear That Drug Eluting Balloons Work |
7:34 AM - 7:39 AM | Prevention And Treatment Of In-Stent Restenosis |
7:40 AM - 7:45 AM | Will Long Nitinol Stents (Like the 20 cm EVERFLEX) Replace Bypass Surgery For Long Fempop Occlusions? |
7:46 AM - 7:58 AM | Panel Discussion |
END OF SESSION 10 | |
SESSION 11 SCHEDULE | |
Thursday
SESSION 11:
MORE LOWER EXTREMITY HOT TOPICS, ESPECIALLY REGARDING STENTS (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
7:59 AM - 8:04 AM | Role Of Current Stents In Lower Extremity Occlusive Disease In 2009: What Is The Most Recent Evidence Including That From The STRIDES And VIASTAR Studies? |
8:05 AM - 8:10 AM | 2-Year Results Of The ZILVER-PTX Drug-Eluting Stent For SFA Lesions |
Presenters(s):Michael D. Dake, MD | |
8:11 AM - 8:16 AM | Status Of The TURBO BOOSTER Spectranetics Laser For Lower Extremity Occlusive Disease: Has It Changed Things? |
8:17 AM - 8:22 AM | New Concepts In Stent Design: The Micromesh-Covered SESAME Stent: Design And Clinical Experience |
8:23 AM - 8:28 AM | Technical Tips And Results Of Transpedal Approach For Revascularizing Tibial Artery Occlusions Which Cannot Be Crossed From Above |
8:29 AM - 8:34 AM | Indication And Techniques For Transpedal Approach In The Treatment Of Critical Limb Ischemia |
8:35 AM - 8:40 AM | New Technique For Distal PTA Of Tibial Arteries: The Pedal Arch Route For Access: Can It Work In Diabetics? |
8:41 AM - 8:46 AM | Need For Distal Embolic Filtration Devices With Lower Extremity Atherectomy And Laser Angioplasty |
8:47 AM - 8:52 AM | Incidence Of Embolization After Lower Extremity Percutaneous Revascularization |
8:53 AM - 8:58 AM | Choice Of Access For Below-Knee Interventions: Up And Over vs. Antegrade |
8:59 AM - 9:10 AM | Panel Discussion |
END OF SESSION 11 | |
SESSION 12 SCHEDULE | |
Thursday
SESSION 12:
MORE LOWER EXTREMITY HOT TOPICS (5-MINUTE TALKS)
xxxx
Moderators:Frank J. Veith, MD / TBD
|
|
x | |
9:10 AM - 9:15 AM | Devices And Simplified Strategies For Crossing Total Occlusions |
9:16 AM - 9:21 AM | Value And Limitations Of Drug-Eluting Stents (DES) In The Treatment Of Critical Limb Ischemia (CLI) |
9:22 AM - 9:27 AM | DES vs. Bare Metal Stents (BMS) To Treat Below-Knee Lesions: 1-Year Angiographic Results Of The DESTINY Trial |
9:28 AM - 9:33 AM | Below-Knee DES For CLI: Results With 2-Year Follow-Up |
9:34 AM - 9:39 AM | Intraoperative Stem Cell Treatment Delivered With A Novel Device To Improve Limb Salvage Rates |
9:40 AM - 9:45 AM | Debate 6: DES In The SFA Will Have A Positive Impact |
9:46 AM - 9:51 AM | Debate 6: DES In The SFA Are Not Needed |
9:52 AM - 9:57 AM | 5-Year Results With Zilver Stents Across The Knee Are Good |
9:58 AM - 10:03 AM | With Foot Gangrene And Ulceration Wound Healing Occurs Faster And Better With A Bypass Than With Endovascular Treatments |
10:04 AM - 10:18 AM | Panel Discussion CONCLUSION OF PROGRAMS A AND B. AIMsymposium continues in the Trianon Ballroom, 3rd Floor as Plenary Sessions. VEITHsymposium continues in the Grand Ballroom, 3rd Floor as Plenary Sessions. |
END OF SESSION 12 | |
SESSION 13 SCHEDULE | |
Thursday
SESSION 13:
IMAGING FOR VASCULAR INTERVENTION
Moderators:TBD
|
|
x | |
11:00 AM - 11:10 AM | Preprocedural Imaging MRA Or CTA: Which Is Best For Evaluation Of PVD? |
Presenters(s):Barry Stein, MD, FSIR, FACR | |
11:10 AM - 11:20 AM | Preprocedural Imaging MRA Or CTA: Which Is Best For Evaluation Of Aortic And Visceral Disease? |
Presenters(s):Robert A. Lookstein, MD, FSIR, FAHA | |
11:20 AM - 11:30 AM | Improved MRA With Improved Blood Pool Contrast |
11:30 AM - 11:40 AM | In Patients With Renal Insufficiency, MRA Can Be Performed Adequately Without Contrast |
Presenters(s):Eli Atar, MD | |
11:40 AM - 11:50 AM | How To Grow Your Interventional Practice Using Cross-Sectional Imaging |
Presenters(s):Timothy W.I. Clark, MD | |
11:50 AM - 12:00 PM | The IR Suite Of The Future Is Here Today: How We Have Incorporated Imaging And Surgery In Our Center |
Presenters(s):Barry T. Katzen, MD | |
12:00 PM - 12:10 PM | Technical Tips For CO2 Angiography |
Presenters(s):James Caridi, MD | |
12:10 PM - 12:20 PM | The Value Of Fluoro CT For Vascular And Non Vascular Intervention |
12:20 PM - 12:30 PM | Fluoro-TRACE: A New Roadmapping Technique That Simplifies Vascular Intervention |
Presenters(s):Jacob Cynamon, MD | |
12:30 PM - 12:40 PM | Panel Discussion |
12:40 PM - 1:20 PM | Lunch Break |
END OF SESSION 13 | |
SESSION 14 SCHEDULE | |
Thursday
SESSION 14:
SFA/POPLITEAL/TIBIAL DISEASE
Moderators:TBD
|
|
x | |
1:20 PM - 1:30 PM | What Is The Best Medical Treatment For PVD? |
Presenters(s):Andrew S. Blum, MD | |
1:30 PM - 1:40 PM | Intermittent Claudication: What Have We Learned From The Randomized Trials? |
Presenters(s):Timothy P. Murphy, MD | |
1:40 PM - 1:50 PM | New And Improved Stents Can Improve Results Of SFA Stenting |
Presenters(s):Götz M. Richter, MD, PhD | |
1:50 PM - 2:00 PM | The Contemporary “CLI Tool Box”: New Devices Including Atherectomy Devices And New Crossing Systems |
Presenters(s):Gary M. Ansel, MD | |
2:00 PM - 2:10 PM | Crossing Long Tibial Occlusions: Technical Tips |
Presenters(s):Gary M. Ansel, MD | |
2:10 PM - 2:20 PM | The Micromesh-Covered Stent (SESAME Stent): A New Concept In Stent Design |
2:20 PM - 2:30 PM | Current Status Of Angiogenesis In Patients With Non Reconstructible PVD |
2:30 PM - 2:40 PM | Popliteal Aneurysms: Stent-Grafts Should Be The Preferred Mode Of Treatment |
Presenters(s):Barry T. Katzen, MD | |
2:40 PM - 2:50 PM | Duplex Guided PTA: Is It Truly Feasible Or Is It A Hoax? |
2:50 PM - 3:00 PM | Outpatient Endovascular Procedures: What Can And Cannot Be Done In The Outpatient Center? |
3:00 PM - 3:30 PM | Panel Discussion |
END OF SESSION 14 | |
SESSION 15 SCHEDULE | |
x | |
3:30 PM - 3:40 PM | Improving Renal Perfusion During Contrast Studies May Help Preserve Renal Function In Patients With Renal Insufficiency |
Presenters(s):John H. Rundback, MD, FSIR, FAHA | |
3:40 PM - 3:50 PM | Renal Intervention: Techniques And Results Of A Large Single Center Study |
Presenters(s):Thomas A. Sos, MD | |
3:50 PM - 4:00 PM | New Improved Renal Stent Systems: Is Smaller Better? |
Presenters(s):Götz M. Richter, MD, PhD | |
4:00 PM - 4:10 PM | What Have We Learned From The Randomized Renal Artery Stent Trials? |
Presenters(s):Timothy P. Murphy, MD | |
4:10 PM - 4:20 PM | Panel Discussion |
END OF SESSION 15 | |
SESSION 16 SCHEDULE | |
x | |
4:20 PM - 4:30 PM | Venous Thromboembolic Disease: Randomized Prospective Trial To Determine Efficacy Of Aggressive Management Of DVT |
4:30 PM - 4:40 PM | Tips And Tricks For Stenting Chronic Venous Occlusions |
4:40 PM - 4:50 PM | Outpatient Treatment Of DVT |
4:50 PM - 5:00 PM | Optional IVC Filter Removal: Tips For Difficult Cases |
Presenters(s):David W. Trost, MD | |
5:00 PM - 5:10 PM | Fatal Complications Of Interventional Management Of SVC Syndrome |
Presenters(s):Jacob Cynamon, MD | |
5:10 PM - 5:20 PM | Panel Discussion |
END OF SESSION 16 | |
SESSION 17 SCHEDULE | |
Thursday
SESSION 17:
UTERINE FIBROID EMBOLIZATION/PELVIC ARTERIOVENOUS MALFORMATION
Moderators:TBD
|
|
x | |
5:20 PM - 5:30 PM | Pelvic Congestion Syndrome And Varicoceles: New Treatment Techniques Based On Recent Data |
5:30 PM - 5:40 PM | Step-By-Step Principles And New Approaches In Treating High Flow Pelvic AVMs |
Presenters(s):Robert J. Rosen, MD | |
5:40 PM - 5:50 PM | Overview Of Uterine Fibroids And Their Management |
Presenters(s):David N. Siegel, MD | |
5:50 PM - 6:00 PM | We Can Now Recommend UFE To Patients Who Want To Maintain Or Improve Their Fertility – Or Can We? |
6:00 PM - 6:10 PM | Tried And True Embolic Agent For UFE: Why Gamble When The Results Are So Good? |
6:10 PM - 6:20 PM | We Can Do Better: A New Embolic Agent With Improved Features |
Presenters(s):Götz M. Richter, MD, PhD | |
6:20 PM - 6:30 PM | Comparing New Entrants To Established Standards: Quantitative In Vitro And In Vivo Comparisons Of Embozene To Embosphere |
6:30 PM - 6:40 PM | Panel Discussion |
END OF SESSION 17 |